Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Deutsch

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Anticancer Research|March 28, 2023
Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast CancerStefan Stefanovic, Ralph Wirtz, Marc Sütterlin, et al.
JMIR Human Factors|March 5, 2024
Usability and User Experience of an mHealth App for Therapy Support of Patients With Breast Cancer: Mixed Methods Study Using Eye TrackingCarolin Anders, Preetha Moorthy, Laura Svensson, et al.
International Journal of Cancer|May 30, 2020
Time trends of neoadjuvant chemotherapy for early breast cancerFabian Riedel, Ann Sophie Hoffmann, Mareike Moderow, et al.
In Vivo (Athens, Greece)|February 26, 2025
Correlation of HLA-A and HLA-B/C Expression With PD-1 and PD-L1 Expression in Patients With Metastatic Breast Cancer as a Potential Prognosticator of Favorable SurvivalLukas Goerdt, Aleksandra Stefanovic, Ralph Wirtz, et al.
Anticancer Research|January 31, 2025
Correlation of HLA-A and HLA-B/C Expression With ESR1 Expression in Patients With Metastatic Breast Cancer as a Potential Prognosticator of Favorable Distant Disease-free SurvivalLukas Goerdt, Aleksandra Stefanovic, Ralph Wirtz, et al.
Cancers|March 14, 2019
Molecular Subtype Conversion between Primary and Metastatic Breast Cancer Corresponding to the Dynamics of Apoptotic and Intact Circulating Tumor CellsStefan Stefanovic, Thomas M Deutsch, Ralph Wirtz, et al.
Archives of Gynecology and Obstetrics|July 22, 2023
Relationship of Ki-67 index in biopsies of metastatic breast cancer tissue and circulating tumor cells (CTCs) at the time of biopsy collectionThomas M Deutsch, Chiara Fischer, Fabian Riedel, et al.
Diagnostics (Basel, Switzerland)|June 10, 2020
Impact of mRNA-Assessed Molecular Subtype Conversion, Intact and Apoptotic Circulating Tumor Cells on Survival of Metastatic Breast Cancer Patients: Proof of PrincipleStefan Stefanovic, Thomas M Deutsch, Ralph Wirtz, et al.
Breast Cancer Research and Treatment|May 22, 2020
HER2-targeted therapy influences CTC status in metastatic breast cancerThomas M Deutsch, Sabine Riethdorf, Carlo Fremd, et al.
JCO Clinical Cancer Informatics|December 23, 2024
Machine Learning to Predict the Individual Risk of Treatment-Relevant Toxicity for Patients With Breast Cancer Undergoing Neoadjuvant Systemic TreatmentLie Cai, Thomas M Deutsch, Chris Sidey-Gibbons, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Anticancer Research|March 28, 2023
Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast CancerStefan Stefanovic, Ralph Wirtz, Marc Sütterlin, et al.
JMIR Human Factors|March 5, 2024
Usability and User Experience of an mHealth App for Therapy Support of Patients With Breast Cancer: Mixed Methods Study Using Eye TrackingCarolin Anders, Preetha Moorthy, Laura Svensson, et al.
International Journal of Cancer|May 30, 2020
Time trends of neoadjuvant chemotherapy for early breast cancerFabian Riedel, Ann Sophie Hoffmann, Mareike Moderow, et al.
In Vivo (Athens, Greece)|February 26, 2025
Correlation of HLA-A and HLA-B/C Expression With PD-1 and PD-L1 Expression in Patients With Metastatic Breast Cancer as a Potential Prognosticator of Favorable SurvivalLukas Goerdt, Aleksandra Stefanovic, Ralph Wirtz, et al.
Anticancer Research|January 31, 2025
Correlation of HLA-A and HLA-B/C Expression With ESR1 Expression in Patients With Metastatic Breast Cancer as a Potential Prognosticator of Favorable Distant Disease-free SurvivalLukas Goerdt, Aleksandra Stefanovic, Ralph Wirtz, et al.
Cancers|March 14, 2019
Molecular Subtype Conversion between Primary and Metastatic Breast Cancer Corresponding to the Dynamics of Apoptotic and Intact Circulating Tumor CellsStefan Stefanovic, Thomas M Deutsch, Ralph Wirtz, et al.
Archives of Gynecology and Obstetrics|July 22, 2023
Relationship of Ki-67 index in biopsies of metastatic breast cancer tissue and circulating tumor cells (CTCs) at the time of biopsy collectionThomas M Deutsch, Chiara Fischer, Fabian Riedel, et al.
Diagnostics (Basel, Switzerland)|June 10, 2020
Impact of mRNA-Assessed Molecular Subtype Conversion, Intact and Apoptotic Circulating Tumor Cells on Survival of Metastatic Breast Cancer Patients: Proof of PrincipleStefan Stefanovic, Thomas M Deutsch, Ralph Wirtz, et al.
Breast Cancer Research and Treatment|May 22, 2020
HER2-targeted therapy influences CTC status in metastatic breast cancerThomas M Deutsch, Sabine Riethdorf, Carlo Fremd, et al.
JCO Clinical Cancer Informatics|December 23, 2024
Machine Learning to Predict the Individual Risk of Treatment-Relevant Toxicity for Patients With Breast Cancer Undergoing Neoadjuvant Systemic TreatmentLie Cai, Thomas M Deutsch, Chris Sidey-Gibbons, et al.
Pageof 4